Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic
Condition(s) studied
Investigational drug(s) / intervention(s)
Thoracic CT scan: Automated quantitative analysis of altered pulmonary volume
Study summary
Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example.
This study aims at assessing the correlation between the amount of radiologic pulmonary alteration and the clinical severity in two clinical situation :
1. SARS-CoV-2 infections
2. Postoperative hypoxemic acute respiratory failure.
Eligibility
Primary outcome measure(s)
- Correlation between altered pulmonary volume and ordinal severity scale — 2 days after CT scan (Day 2)
This criterion will be expressed as a score between 1 (least severe) and 7 (most severe).
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Service d'anesthésie réanimation-CHU de Nancy | Nancy | France | |
| Service d'Anesthésie-Réanimation - CHU Strasbourg | Strasbourg | France |
More University Hospital, Strasbourg, France trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05278390 on ClinicalTrials.gov ↗ ← All trials in France